HIF1A and familial pancreatic carcinoma: Interestingly, the administration of naphthofluorescein, which inhibits Mint3-mediated HIF-1 activation, enhanced the antitumor effects of gemcitabine and doxorubicin in pancreatic cancer and TNBC tumors, respectively, in mouse xenograft models [26].